HDAC inhibitors were found to increase DNA binding and transactivation activity of AP-1 transcription factor via ERK activation, increase expression of c-Jun (Jun activation domain binding protein) and induce its phosphorylation in SH-SY5Y neuroblastoma cells [65,98]. The gene discussed is HDAC9; the disease is neuroblastoma.